Rocket


Overview
Financials
News + Filings

 
 

Eliem Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19
Revenues8.82.5
            Revenue growth248.4% 
Cost of goods sold8.82.5
Gross profit0.00.0
            Gross margin0.0%0.0%
General and administrative2.40.7
EBIT-11.8-4.7
            EBIT margin-134.2%-186.6%
Pre-tax income-23.0-7.4
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-23.0-7.4
            Net margin-261.8%-293.6%
 
Diluted EPS($5.25)($2.22)
Shares outstanding (diluted)4.43.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy